LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 94.68 | 17.25 | 5530 | 6239 | 0.8863 | 0.9718 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 3.06 | 17.25 | 297 | 143 | 2.0738 | 1.5397 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 3.06 | 17.25 | 3 | 143 | 0.0209 | -0.4361 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 3.06 | 17.25 | 291 | 143 | 2.0319 | 1.5227 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 5.03 | 17.25 | 526 | 273 | 1.9242 | 1.3569 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 5.03 | 17.25 | 2 | 273 | 0.0073 | -0.4176 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 5.03 | 17.25 | 495 | 273 | 1.8108 | 1.3213 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 7.01 | 17.25 | 658 | 389 | 1.6893 | 1.2473 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 7.01 | 17.25 | 2 | 389 | 0.0051 | -0.3807 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 7.01 | 17.25 | 657 | 389 | 1.6868 | 1.2466 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 8.98 | 17.25 | 666 | 445 | 1.4964 | 1.1795 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 8.98 | 17.25 | 3 | 445 | 0.0067 | -0.3114 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 8.98 | 17.25 | 721 | 445 | 1.6200 | 1.2167 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 10.95 | 17.25 | 673 | 471 | 1.4271 | 1.1547 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 10.95 | 17.25 | 7 | 471 | 0.0148 | -0.1722 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 10.95 | 17.25 | 747 | 471 | 1.5841 | 1.2024 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 12.91 | 17.25 | 1 | 494 | 0.0020 | -0.4446 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 12.91 | 17.25 | 707 | 494 | 1.4287 | 1.1529 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 12.91 | 17.25 | 3 | 494 | 0.0061 | -0.3032 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 12.91 | 17.25 | 762 | 494 | 1.5398 | 1.1865 | MN20160310_N02 | E18 |